Egyptian Ibnsina Pharma reports 55% y/y profit surge to $19.1mn in 2025

By bna Cairo bureau March 3, 2026

Egyptian pharmaceutical distributor Ibnsina Pharma (EGX: ISPH) announced a remarkable 55% year-on-year (y/y) increase in net profits for 2025, reaching EGP 952mn ($19.1mn), up from EGP 614.56mn in ...


This content is only available to Intellinews Pro users.

If you a Pro users click to login or request a trial.


Thank You,
bne IntelliNews Team

Dismiss
liveChat() ?>